Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency: A cooperative, retrospective study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 6, 1996, Pages 742-748

  Pabinger, Ingrid ^a   Schneider, Barbara ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

antithrombin III deficiency; natural inhibitor deficiency; protein C deficiency; protein S deficiency; thrombotic risk

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; BLOOD CLOTTING INHIBITOR; HEPARIN; ORAL CONTRACEPTIVE AGENT; PROTEIN C; PROTEIN S;

ABDOMINAL SURGERY; ADOLESCENT; ADULT; ANTITHROMBIN III DEFICIENCY; ARTICLE; CHILD; CLINICAL TRIAL; DOPPLER ECHOGRAPHY; ELECTROIMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNODIFFUSION; IMMUNOELECTROPHORESIS; LEG INJURY; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; MESENTERIC VEIN THROMBOSIS; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PHLEBOGRAPHY; PREGNANCY; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; QUALITY OF LIFE; RECURRENCE RISK; THROMBOEMBOLISM; THROMBOPHLEBITIS; THROMBOSIS;

EID: 0029975366     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.6.742     Document Type: Article

References (22)

1. Thaler E, Lechner K. Antithrombin III deficiency and thromboembolism. Clin Haematol. 1981;10:369-390.
2. Griffin JH, Evatt B, Zimmermann TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest. 1981;68:1370-1373.
3. Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH. Plasma protein S in familial thrombotic disease. Blood. 1984;64: 1297-1300.
4. Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest. 1984;74:2082-2088.
5. Bovill EG, Bauer KA, Dickermann JD, Callas P, West B. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood. 1989;73:712-717.
6. Demers C, Ginsberg JS, Hirsh J, Henderson P, Blajchman MA. Thrombosis in antithrombin III-deficient persons: report of a large kindred and literature review. Ann Intern Med. 1992;116: 754-761.
7. Engesser L, Broekmans AW, Briet E, Brommer EJP, Bertina RM. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med. 1987;107:677-682.
8. Allart CF, Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, Briet E. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet. 1993;341:134-138.
9. Pabinger I, Kyrie PA, Heistinger M, Eichinger S, Wittmann E, Lechner K. The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency: a prospective cohort study. Thromb Haemost. 1994;71:441-445.
10. Malm J, Laurell M, Nilsson IM, Dahlbäck B. Thromboembolic disease: critical evaluation of laboratory investigation. Thromb Haemost. 1992;68:7-13.
11. Pabinger I, Brücker S, Kyrie PA, Schneider B, Korninger HC, Niessner H, Lechner K. Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for a rational patient screening. Blood Coagulation Fibrinol. 1992;3:547-553.
12. Tabernero MD, Tomas JF, Alberca I, Orfao A, Lopez-Borrasca A, Vicente V. Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis. Am J Hematol. 1991;36: 249-254.
13. Comp PC, Doray D, Patton D, Esmon CT. An abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood. 1986;67:504-508.
14. Thommen D, Buhrfeind E, Felix R, Sulzer I, Furlan M, Lämmle B. Hämostaseparameter bei 55 Patienten mit venösen und/oder arteriellen Thrombembolien. Schweiz Med Wschr. 1989;119:493-499.
15. SAS Language. Version 6, 1st edition. Cary NC: SAS Institute Inc; 1990.
16. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med. 1994;330:517-522.
17. Pabinger I, Schneider B, and the GTH-Study Group on Natural Inhibitors. Thrombotic risk of women with hereditary antithrombin III-, protein C- and protein S-deficiency taking oral contraceptive medication. Thromb Haemost. 1994;71:548-552.
18. Conard J, Horellou MH, Van Dreden P, Lecompte T, Samama M. Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women. Thromb Haemost. 1990; 63:319-320.
19. De Stefano V, Leone G, Mastrangelo S, Tripodi A, Rodeghiero F, Castaman G, Barbui T, Finazzi G, Bizzi B, Mannucci PM. Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow up after diagnosis of 138 patients with congenital deficiency of antithrombin III. protein C, protein S. Thromb Haemost, 1994:72:352-358.
20. De Stefano V, Leone G, Mastrangelo S, Tripodi A, Rodeghiero F, Castaman G, Barbui T, Finazzi G, Bizzi B, Mannucci PM. Thrombosis during pregnancy and surgery in patients with congenital deficiency of antithrombin III, protein C, protein S. Thromb Haemost. 1994;71:799-800. Letter.
21. Koeleman BPC, Reitsma PH, Allart CF, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C deficient families. Blood. 1994;84:1031-1035.
22. Rosendaal FR, Heijboer J, Briet E, Buller HR, Brandjes DPM, de Bruin K, Hommes DW, Vandenbrouke JP. Mortality in hereditary antithrombin III deficiency-1830-1989. Lancet. 1991;337:260-262.